show index hide index
In Argiésans, in the Territoire de Belfort, a 4-year-old child, Côme, uses innovative technology to better manage his type 1 diabetes. Thanks to the advancement of artificial intelligence and an intelligent insulin pump, Côme benefits from continuous and adjusted monitoring of their state of health. This innovation, although recent, could revolutionize the management of diabetes in many patients.
Technology at the service of Como
Côme, a young resident of Argiésans, received a small box which may seem innocuous at first glance, but which has changed his daily life. This box is none other than a smart insulin pump. Using artificial intelligence, this device adjusts insulin delivery based on the child’s specific needs.
Diabetes regulation using artificial intelligence
The innovation brought by artificial intelligence in the treatment of diabetes is considerable. Mobile applications now make it possible to calculate the exact amount of carbohydrates ingested, using only photos of meals. This data is then integrated into the calculation of the insulin doses needed for Como.
A step forward in diabetes management
For children with type 1 diabetes, careful management is essential. The smart insulin pump’s ability to anticipate and respond to changes in blood glucose levels allows for effective prevention of hypoglycemia. Researchers, such as Professor Monia Rekik, are working to improve these systems for greater reliability and precision.
Perception and knowledge about AI
Despite the obvious benefits, the perception of artificial intelligence in diabetes management is slowly evolving. A recent study shows that the average understanding of these technologies does not exceed 1.48 on a scale of 12. The future of this technology nevertheless promises significant advances to improve the quality of life of diabetic patients.
The potential impact of artificial intelligence in the treatment of diabetes
The possibility of optimized care thanks to artificial intelligence encourages us to rethink the treatment of diabetes. Real-time adaptation of treatments could significantly reduce complications linked to this disease, providing patients like Como with increased autonomy and improved quality of life.
